The Role of Topotecan in the Treatment of Brain Metastases

The Role of Topotecan in the Treatment of Brain Metastases Eric T. Wong, Anna Berkenblit Oncologist 2004; 9: 68-79 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in neuro-oncology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the role of chemotherapy in the treatment of brain metastases. Identify the properties of topotecan that are conducive to treating patients with brain metastases. Discuss the investigation of single-agent topotecan and topotecan in combination with other chemotherapeutic agents or radiotherapy in the treatment of brain metastases. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jan. 30, 2004 Most Recent Review: Jan. 30, 2004* Most Recent Update: Jan. 30, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.